Survey on Practice and Comparison With Best Evidence in Surgical Site Infection Prevention in Colorectal Surgery (PREVISQCOR)

October 8, 2019 updated by: Josep Maria Badia, Hospital de Granollers

Awareness of Practice and Comparison With Best Evidence in Surgical Site Infection Prevention in Colorectal Surgery

Web-based survey to colorectal surgeons assessing knowledge, beliefs and practices regarding the use of preventative measures for SSI.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

A web-based survey (SurveyMonkey©; https://es.surveymonkey.com/r/FBVR59C) to the members of the Colorectal Chapter of the Spanish Association of Surgeons (AEC) and the Spanish Association of Coloproctology (AECP). A link to the web page containing the survey is disseminated via email, newsletter and Twitter.

A board from the Surgical Infection Section did a review of evidence and previous guidelines to be used in the evaluation of the results. The most recent clinical practice guidelines have been analysed. Furthermore, an extensive review of specific measures for colorectal surgery has been published and used for evaluation. According to the review, the preventive measures analysed in the survey have been distributed into two groups: high or low level of evidence.

The survey aim to assess knowledge, beliefs, and practices of attending colorectal surgeons on preventative measures including mechanical bowel preparation (MBP), oral antibiotic prophylaxis and the use of drains. Furthermore, the questions address the level of accordance between their beliefs and the protocols or the usual practice of their units. The agreement rate between the beliefs and usual practice of all respondents will be calculated on a scale from 0 to 100. For discussion, the responses on the implementation of major surgical site infection (SSI) prevention measures will be compared with the recommendations of the expert group. Other questions are related to the types of complications that surgeons believe are prevented by the use of oral antibiotic prophylaxis or MBP, reasons for not using either of them, type of oral and systemic antibiotics and cathartics used, and strategies already in place or that should be implemented to reduce SSI rates at respondents' hospitals.

The results will be expressed in percentages on the total answers obtained. Responses will be entered into a computerized database that will be analysed using the SPSS program (v.10.0, Chicago, IL, USA). The results will be analysed using the chi-square test with statistical significance defined as p <0.05.

Study Type

Observational

Enrollment (Actual)

355

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Barcelona
      • Granollers, Barcelona, Spain, 08402
        • Fundació Privada Hospital Asil de Granollers

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Members of the Colorectal Chapter of the Spanish Association of Surgeons (AEC) and the Spanish Association of Coloproctology (AECP)

Description

Inclusion Criteria:

  • Colorectal surgeons members of the Colorectal Chapter of the Spanish Association of Surgeons (AEC) and the Spanish Association of Coloproctology (AECP)

Exclusion Criteria:

  • none

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Colorectal surgeons
Survey among Spanish colorectal surgeons
Survey among colorectal surgeons

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Awareness of practice - Percentage of responders who use each preventive measures for surgical site infection
Time Frame: 2019
Percentage of responders who use each preventive measures for surgical site infection (including mechanical bowel preparation and oral antibiotic prophylaxis), compared to their beliefs and knowledge of scientific evidence.
2019

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Josep M Badia, Universitat Internacional de Catalunya

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2018

Primary Completion (Actual)

June 30, 2019

Study Completion (Actual)

July 30, 2019

Study Registration Dates

First Submitted

March 11, 2019

First Submitted That Met QC Criteria

March 19, 2019

First Posted (Actual)

March 20, 2019

Study Record Updates

Last Update Posted (Actual)

October 9, 2019

Last Update Submitted That Met QC Criteria

October 8, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Surgical Site Infection

Clinical Trials on Survey

3
Subscribe